// App-Quantinova.ai

: COPD exacerbations significantly impact quality of life as measured by SGRQ-C total score: results from the FLAME study

Researchers

Presenter

  • Nicolas Roche

Principal Investigators

  • Jadwiga A Wedzicha

  • Francesco Patalano

  • Stefan-Marian Frent

  • Michael Larbig

  • Steven Shen

  • Robert Fogel

  • Donald Banerji

Medical Centers

  • Service de Pneumologie AP-HP, University Paris Descartes, Paris, France

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • Novartis AG, Basel, Switzerland

  • European Respiratory Society Fellow at Novartis Pharma AG, Basel, (Switzerland); Department of Pulmonology, University of Medicine and Pharmacy “Victor Babes” Timisoara,, Timisoara, Romania

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

Locations

  • France

  • United Kingdom

  • Switzerland

  • Romania

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved